Zealand Pharma A/S
ZLDPF
$64.38
$1.131.78%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.14M | 1.29M | 650.60K | 4.92M | 2.20M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.14M | 1.29M | 650.60K | 4.92M | 2.20M |
| Cost of Revenue | 57.10K | 58.30K | -975.50K | 1.37M | 669.30K |
| Gross Profit | 1.08M | 1.24M | 1.63M | 3.56M | 1.53M |
| SG&A Expenses | 14.51M | 22.01M | 13.82M | 11.66M | 10.98M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 3.04M | -448.30K | 462.30K | -- | -- |
| Total Operating Expenses | 58.56M | 57.91M | 52.14M | 43.55M | 39.45M |
| Operating Income | -57.42M | -56.61M | -51.49M | -38.62M | -37.25M |
| Income Before Tax | -47.50M | -41.67M | -39.46M | -42.43M | -33.49M |
| Income Tax Expenses | -194.10K | -82.00K | -202.60K | -189.90K | -196.90K |
| Earnings from Continuing Operations | -47.30M | -41.59M | -39.26M | -42.24M | -33.29M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -47.30M | -41.59M | -39.26M | -42.24M | -33.29M |
| EBIT | -57.42M | -56.61M | -51.49M | -38.62M | -37.25M |
| EBITDA | -56.58M | -56.24M | -50.58M | -37.65M | -36.29M |
| EPS Basic | -0.67 | -0.59 | -0.56 | -0.67 | -0.54 |
| Normalized Basic EPS | -0.44 | -0.38 | -0.38 | -0.44 | -0.35 |
| EPS Diluted | -0.67 | -0.59 | -0.56 | -0.67 | -0.54 |
| Normalized Diluted EPS | -0.44 | -0.38 | -0.38 | -0.44 | -0.35 |
| Average Basic Shares Outstanding | 70.60M | 70.74M | 70.66M | 62.69M | 61.63M |
| Average Diluted Shares Outstanding | 70.60M | 70.74M | 70.66M | 62.69M | 61.63M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |